These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Classification of neuroleptics: implications for tardive dyskinesia. Christensen AV Pol J Pharmacol Pharm; 1985; 37(3):295-309. PubMed ID: 2866499 [TBL] [Abstract][Full Text] [Related]
3. Animal models of tardive dyskinesia: their use in the search for new treatment methods. Goetz CG; Klawans HL; Carvey P Mod Probl Pharmacopsychiatry; 1983; 21():5-20. PubMed ID: 6140633 [No Abstract] [Full Text] [Related]
11. Dopamine receptor sensitivity changes with chronic stimulants. Lee TH; Ellinwood EH; Nishita JK Ann N Y Acad Sci; 1988; 537():324-9. PubMed ID: 3059930 [No Abstract] [Full Text] [Related]
12. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia. Yarbrough GG; Faison EP; Antolik EK Neurosci Lett; 1982 Dec; 34(3):321-3. PubMed ID: 6819493 [TBL] [Abstract][Full Text] [Related]
13. [Tardive dyskinesia: problems of pathogenesis, treatment and prevention]. Olajossy M Psychiatr Pol; 1980; 14(6):621-5. PubMed ID: 6112766 [No Abstract] [Full Text] [Related]